Werkgroep Cardiologische centra Nederland

DAPA-HFrEF (Follow-up)

An International, Multicenter, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients with Chronic HFrEF
Medicine
dapagliflozin
Population
Heart failure
Phase
III
Starting year
2016

Director of Study

drs. C. de Nooijer (Cardioloog)
Veldhoven, Máxima Medisch Centrum